
GSK vs IMRN
$GSK vs $IMRN head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs IMRN: the quick read
- ·GSK is the larger company by market cap ($100.14B vs $8M).
- ·GSK has been more active on our scanner (65 vs 4 alerts in 30 days).
- ·IMRN has the smaller float (8.1M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: IMRN is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·GSK draws far more of our scanner's attention, 65 unusual-volume alerts in 30 days against 4, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: GSK is more than 12634x the market cap of IMRN, so the same dollar of news moves IMRN far harder.
- ·GSK pays a dividend and IMRN does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and IMRN on TheDesperateTrader.
- Is GSK or IMRN the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($100.14B vs $8M). GSK has been more active on our scanner (65 vs 4 alerts in 30 days). IMRN has the smaller float (8.1M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and IMRN?
- The differences that matter: GSK is roughly 12634x the size of the other by market cap ($100.14B vs $8M); they trade at very different share prices ($49.45 vs $0.96); GSK sits at 35% of its 52-week range against 17% for IMRN; only GSK pays a dividend; our scanner flagged GSK 65 times in the last 30 days against 4 for IMRN. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and IMRN is more active right now?
- Right now GSK is at about 1.5x its normal volume and IMRN is at about 0.0x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or IMRN? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.